title: Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008.
abstract: BACKGROUND
  Antibiotic prophylaxis is an important component of dermatologic surgery, and recommendations in this area should reflect the updated 2007 guidelines of the American Heart Association, the American Dental Association with the American Academy of Orthopaedic Surgeons guidelines, and recent prospective studies on surgical site infection.
  
  
  OBJECTIVE
  To provide an update on the indications for antibiotic prophylaxis in dermatologic surgery for the prevention of infective endocarditis, hematogenous total joint infection, and surgical site infection.
  
  
  METHODS
  A literature review was performed, expert consensus was obtained, and updated recommendations were created, consistent with the most current authoritative guidelines from the American Heart Association and the American Dental Association with the American Academy of Orthopaedic Surgeons.
  
  
  RESULTS
  For patients with high-risk cardiac conditions, and a defined group of patients with prosthetic joints at high risk for hematogenous total joint infection, prophylactic antibiotics are recommended when the surgical site is infected or when the procedure involves breach of the oral mucosa. For the prevention of surgical site infections, antibiotics may be indicated for procedures on the lower extremities or groin, for wedge excisions of the lip and ear, skin flaps on the nose, skin grafts, and for patients with extensive inflammatory skin disease.
  
  
  CONCLUSIONS
  These recommendations are not based on multiple, large-scale, prospective trials.
  
  
  CONCLUSIONS
  There is a strong shift away from administration of prophylactic antibiotics in many dermatologic surgery settings, based on updated authoritative guidelines. These recommendations provide guidance to comply with the most current guidelines, modified to address dermatology-specific considerations. Managing physicians may utilize these guidelines while individualizing their approach based on all clinical considerations.
authors.affiliation: Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA. wright.cristina@mayo.edu
authors.forename: Tina I
authors.initials: TI
authors.lastname: Wright
authors.forename: Larry M
authors.initials: LM
authors.lastname: Baddour
authors.forename: Elie F
authors.initials: EF
authors.lastname: Berbari
authors.forename: Randall K
authors.initials: RK
authors.lastname: Roenigk
authors.forename: P Kim
authors.initials: PK
authors.lastname: Phillips
authors.forename: M Amanda
authors.initials: MA
authors.lastname: Jacobs
authors.forename: Clark C
authors.initials: CC
authors.lastname: Otley
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019072:Antibiotic Prophylaxis / Q000592:standards*; D016470:Bacteremia / Q000150:complications / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000150:complications; D062109:Dermatologic Surgical Procedures; D003880:Dermatology / Q000592:standards*; D004697:Endocarditis, Bacterial / Q000209:etiology / Q000517:prevention & control*; D017408:Guidelines as Topic; D006801:Humans; D016106:Methicillin Resistance; D015580:Mohs Surgery / Q000009:adverse effects / Q000592:standards; D019647:Oral Surgical Procedures / Q000009:adverse effects / Q000592:standards; D016459:Prosthesis-Related Infections / Q000209:etiology / Q000517:prevention & control*; D018570:Risk Assessment; D012307:Risk Factors; D013211:Staphylococcus aureus / Q000187:drug effects; D013530:Surgical Wound Infection / Q000150:complications / Q000382:microbiology / Q000517:prevention & control*; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents